TWO-YEAR DATA COMPAIRING THE EFFICACY OF AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION IN TREATMENT NAIVE AND SWITCHOVER PATIENTS.

被引：0
|
作者：
McKenna, Michael [1 ]
Suleman, Javid [1 ]
Ting, Darren S. J. [1 ]
Pushpoth, Sreekumari [1 ]
Severn, Philip [1 ]
机构：
[1] James Cook Univ Hosp Ophthalmol, NHS, Middlesbrough, Teeside, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
422
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy of Aflibercept in Treatment-naive Neovascular Age-related Macular Degeneration: Two-Year Real World Outcomes
    Eleftheriadou, Maria
    Vazquez-Alfageme, Clara
    Citu, Maria Cristina
    Crosby-Nwaobi, Roxanne R.
    Sivaprasad, Sobha
    Hykin, Philip
    Hamilton, Robin D.
    Patel, Praveen J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [2] The efficacy of treatment with aflibercept intravitreal injections in patients with wet age-related macular degeneration
    Heinke, Anna
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [3] Efficacy of Aflibercept in Refractory Wet Age-Related Macular Degeneration
    Choi, Catherine
    Zhang, Li
    Abramoff, Michael David
    Sonka, Milan
    Shifera, Amde
    Kay, Christine Nichols
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [4] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [5] Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results
    Taipale, Claudia
    Lindholm, Juha-Matti
    Kaarniranta, Kai
    Tuuminen, Raimo
    ADVANCES IN THERAPY, 2020, 37 (05) : 2256 - 2266
  • [6] Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results
    Claudia Taipale
    Juha-Matti Lindholm
    Kai Kaarniranta
    Raimo Tuuminen
    Advances in Therapy, 2020, 37 : 2256 - 2266
  • [7] Preliminary Results of Aflibercept in Treatment-Naive Choroidal Neovascularization of Wet Age-Related Macular Degeneration
    Gambon, R.
    Barthelmes, D.
    Amstutz, C.
    Fleischhauer, J.
    Kurz-Levin, M.
    Zweifel, S.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2014, 231 (04) : 423 - 426
  • [8] Evaluation of the efficacy of aflibercept's in the treatment of neovascular age-related macular degeneration in treatment-naive and switched patients. Report of 86 cases
    Maringe, E.
    Letesson, E.
    Duncombe, A.
    Muraine, M.
    Genevois, O.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (03): : 255 - 260
  • [9] Two-year outcomes of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab
    Izawa, Hidetomo
    Azuma, Keiko
    Matsuda, Aya
    Shimizu, Kimiko
    Tan, Xue
    Inoue, Tatsuya
    Obata, Ryo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [10] Aflibercept for the Treatment of Age-Related Macular Degeneration
    George Trichonas
    Peter K. Kaiser
    Ophthalmology and Therapy, 2013, 2 (2) : 89 - 98
12345